New phase I/II trial explores next-generation lytic immunotherapy CyPep-1 in advanced solid tumors May 27, 2020
FDA approves Dupixent for moderate to severe atopic dermatitis in children aged 6-11 years May 27, 2020
Phase III Archway study of Port Delivery System with ranibizumab in wet AMD meets primary endpoint May 27, 2020
PRIMVAC placental malaria vaccine immunogenic but shows limited cross-reactivity in trial May 27, 2020
RSS